Veracyte, Inc.
VCYT
Kedudukan dalam Saham
#4350
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Harga Saham
$44.93
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$3.61B
Perubahan (1 hari)
2.57%
Perubahan (1 tahun)
24.45%
Negara
US
Perdagangan Veracyte, Inc. (VCYT)
Kategori
Healthcare
Sejarah pecahan saham untuk Veracyte, Inc. (VCYT)
Saham Veracyte, Inc. (simbol: VCYT) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham VCYT yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham VCYT.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham VCYT yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham VCYT.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
